M. Takeshita et al., BONE-MARROW FINDINGS IN MALIGNANT HISTIOCYTOSIS AND OR MALIGNANT-LYMPHOMA WITH CONCURRENT HEMOPHAGOCYTIC SYNDROME, Leukemia & lymphoma, 12(1-2), 1993, pp. 79-89
We examined bone marrow specimens from 19 patients with malignant hist
iocytosis (MH) and/or malignant lymphoma (ML) with concurrent hemophag
ocytic syndrome (HS) who suffered from high fever, hepatosplenomegaly,
liver dysfunction, profound cytopenia, and erythrophagocytosis. There
was little lymph-node enlargement or no tumor formation. The neoplast
ic cells in 3 patients exhibited histiocytes/macrophages phenotype wit
h positive reactions for fluoride-sensitive nonspecific esterase, lyso
zyme and CD68 (KP1). Twelve other patients showed a T-cell (CD3) pheno
type, in which 5 patients expressed CD30 (BerH2) as well. B-cell chara
cteristics with CD20 (L26), CIg. Upsilonlambda and gammakappa were man
ifest in 2 patients, but indeterminate markers were found in the 2 rem
aining patients. Eighteen patients showed an infiltration of large neo
plastic cells mainly with noncohesive interstitial growth pattern, ran
ging from 1.7% to 74.2% of the nucleated cells in the bone marrow. A l
arge number of histiocytes/macrophages and dendritic cells was diffuse
ly observed in 15 patients. Severely decreased hematopoiesis in all th
ree series of hematopoietic cells was found in 16 patients. Bone marro
w infiltration by the neoplastic cells and numerous reactive cells wit
h erythrophagocytosis appears be an important factor of profound cytop
enia in patients of MH and/or ML with HS. The infiltrating pattern of
the neoplastic and reactive cells in the bone marrow of MH and/or ML w
ith HS was different from that of other types of peripheral T-cell ML,
B-cell ML in high grade malignancy, and Hodgkin's disease. Cell chara
cteristics and lineage of the neoplastic cells in MH and/or ML with HS
are also discussed in this study.